Kristian Anderson

PRECISION HEALTH PREVIOUS SPEAKER

Kristian
Anderson
WORK
Scripps Research

Spearheaded several large international collaborations investigating the spread and evolution of severe human pathogens, including SARS-CoV-2, Zika, Ebola, West Nile, and Lassa.

Howard A. Zucker

PRECISION HEALTH PREVIOUS SPEAKER

Howard
A. Zucker
WORK
New York State

Manage New York State’s response to the COVID-19 pandemic and has worked at the helm on such critical issues as the 2018-2019 measles outbreak, vaping-related illnesses, Legionella, the Zika virus, Ebola, and medical marijuana.

Dame Sue

PRECISION HEALTH PREVIOUS SPEAKER

Professor
Dame Sue Hill
WORK
National Health Service

Chief Scientific Officer for England and the head of profession for the healthcare science workforce in the NHS, providing professional leadership and expert clinical advice across the health and care system.

Richard P. Lifton

PRECISION HEALTH PREVIOUS SPEAKER

Richard
P. Lifton
WORK
Rockefeller University

Well-known for his discovery that mutations with large effect on human blood pressure act by altering renal salt reabsorption anddiscoveries that have informed public health efforts and therapeutic strategies used worldwide to prevent heart attacks and strokes.

Mark McCarthy

PRECISION HEALTH PREVIOUS SPEAKER

Mark
McCarthy
WORK
Genentech

Leads efforts within the company to use human genetics to advance the understanding of disease and further the development of novel therapeutic and preventative approaches.

Wendy Chung

PRECISION HEALTH PREVIOUS SPEAKER

Wendy
Chung
WORK
Columbia University

Human genetics of obesity, breast cancer, pulmonary hypertension, and birth defects including congenital diaphragmatic hernia and congenital heart disease.

Robert M. Califf

PRECISION HEALTH PREVIOUS SPEAKER

Robert
M. Califf
WORK
Duke University & Stanford University

Nationally and internationally recognized leader in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research

Eric D. Green

PRECISION HEALTH PREVIOUS SPEAKER

Eric
D. Green
WORK
National Institutes of Health

Human Genome Project and groundbreaking work on mapping, sequencing, and characterizing mammalian genomes

Geoffrey S. Ginsburg

PRECISION HEALTH PREVIOUS SPEAKER

Geoffrey
S. Ginsburg
WORK
Duke University

Translating genomic information into medical practice and the integration of precision medicine into healthcare

Geoffrey S. Ginsburg

PRECISION HEALTH PREVIOUS SPEAKER

Geoffrey
S. Ginsburg
WORK
Duke University

Translating genomic information into medical practice and the integration of precision medicine into healthcare

previous arrow
next arrow

2022 Speakers

Ronald Wapner

Ronald Wapner, MD is a Professor of Obstetrics and Gynecology for Columbia University Irving Medical Center and the Director of Reproductive Genetics. Dr. Wapner is an internationally known physician and researcher specializing in reproductive genetics. He pioneered the development of chorionic villus sampling (CVS) and multi-fetal reduction. He has authored or co-authored over 400 publications and he has been an active investigator in the area of Maternal-Fetal Medicine. He is either a principal or co-investigator for several NICHD-sponsored multi-center studies.

Nicola Mulder

Professor Mulder heads the Computational Biology Division at the University of Cape Town (UCT), and is a full member of the Institute of Infectious Disease and Molecular Medicine. She leads H3ABioNet, a large Pan African Bioinformatics Network of 28 institutions in 17 countries, which aims to develop bioinformatics capacity to enable genomic data analysis on the continent. H3ABioNet has developed an extensive training program for African researchers. She also co-leads a Sickle Cell Disease Data Coordinating Centre and a Wellcome Trust Centre Data Integration Platform at UCT and more recently, the DS-I Africa Open Data Science Platform.

Karen Miga

Karen Miga, assistant professor of biomolecular engineering at UC Santa Cruz, was named one of the 100 most influential people of 2022 by TIME. The honor was announced on May 23.
Miga and her colleagues, Adam Phillippy, Evan Eichler, and Michael Schatz, led an international team of scientists — the Telomere-to-Telomere (T2T) Consortium — to complete the first, gapless sequence of the human genome. Parts of the human genome are now available to study for the first time, allowing researchers to better understand genetic diseases, human diversity, and evolution.

Kelly Frazer

Dr. Frazer is an internationally renowned leader in the field of genome biology. She is the director of UC San Diego Institute for Genomic Medicine and is a professor and founding chief of the Division of Genome Information Sciences in the Department of Pediatrics at UC San Diego. Over the past seven years, Dr. Frazer’s lab has systematically derived and characterized a unique collection of iPSC lines from 222 individuals – referred to as iPSCORE (iPSC Collection for Omic Research). The iPSCORE resource is currently being used to conduct genotype – molecular phenotype correlations in both pluripotent stem cells and iPSC-derived cell types.

Keith Yamamoto

As UCSF’s first vice chancellor for Science Policy and Strategy, Keith Yamamoto leads efforts to anticipate the needs of an increasingly dynamic biomedical research endeavor, and to position UCSF optimally, by working within the University as well as influencing and shaping science policy at the state and national levels and beyond.

Euan Ashley

Born in Scotland, Ashley graduated with 1st class Honors in Physiology and Medicine from the University of Glasgow. He completed medical residency and a PhD at the University of Oxford before moving to Stanford University where he trained in cardiology and advanced heart failure, joining the faculty in 2006. His group is focused on the science of precision medicine. In 2010, he led the team that carried out the first clinical interpretation of a human genome. The article became one of the most cited in clinical medicine that year and was later featured in the Genome Exhibition at the Smithsonian in DC. Over the following 3 years, the team extended the approach to the first whole genome molecular autopsy, to a family of four, and to a case series of patients in primary care. They now routinely apply genome sequencing to the diagnosis of patients at Stanford hospital where Ashley directs the Clinical Genome Program and the Center for Inherited Cardiovascular Disease.

A blond white woman wearing a black sleeveless shirt smiles into the camera.

Gretchen Bandoli

I am an Assistant Professor in the Department of Pediatrics at UC San Diego. My research interests include pregnancy and early childhood determinants of health. I also am interested in the expansion of methodology to characterize complex exposures across gestation, including substances (alcohol, marijuana) and medications. I am a co-investigator of the Study of Mothers and Infants, a large administrative database linked to biospecimens allowing us to study genetic and environmental contributors to pregnancy and child outcomes.

A white woman with long brown hair wearing a white lab coat smiles into the camera.

Allyson Berent

Allyson Berent is a veterinary internal medicine specialist who serves as the Director of Interventional Endoscopy Services at the largest animal hospital in the world, The Animal Medical Center, in New York City. After graduating from Cornell University College of Veterinary Medicine she completed an internship at the University of Minnesota and a residency in Small Animal Internal Medicine at the Veterinary Hospital of the University of Pennsylvania.

A white woman with short, blond, wavy hair, wearing black glasses and a black and white collared jacket, smiles at the camera.

Diana W. Bianchi

Diana W. Bianchi is the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and a Senior Investigator in the Center for Precision Health Research at the National Human Genome Research Institute (NHGRI). She received her M.D. from Stanford and her postgraduate training in Pediatrics, Medical Genetics and Neonatal-Perinatal Medicine at Harvard.

White man with short silver hair wearing glasses looks at the camera and smiles.

Phil Febbo

CHIEF MEDICAL OFFICER

Phil Febbo, MD, was appointed as Chief Medical Officer in March 2018. In this role, he is responsible for developing and executing the Company’s medical strategy to drive genomic testing into healthcare practice. Febbo has a successful track record of translational research, clinical excellence, and for embedding molecular insights into clinical care. 

Daniel MacArthur

ASSISTANT PROFESSOR AT HARVARD MEDICAL SCHOOL

Daniel MacArthur is the Director of the Centre for Population Genomics, based jointly at the Garvan Institute of Medical Research, Sydney, and the Murdoch Children’s Research Institute in Melbourne.

Daniel completed his Ph.D. at the University of Sydney before moving to postdoctoral studies at the Wellcome Trust Sanger Institute in Cambridge, UK, and then a faculty position at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and Harvard in Boston. In this position, he co-directed the Broad Institute’s Program in Medical and Population Genetics, as well as the NIH-funded Center for Mendelian Genomics, which sequenced the exomes, genomes, and/or transcriptomes of over 10,000 individuals from families affected by severe Mendelian disease. He also led the Genome Aggregation Database (gnomAD) consortium, which produced the world’s largest catalogs of human genetic variation, spanning nearly 200,000 individual exomes and genomes.

Daniel returned to Australia in 2020 to lead the new Centre for Population Genomics, which will focus on developing tools and resources useful for the implementation of population-scale genomic medicine in Australia.

A white man with dark-to-grey hair, wearing a blue shirt and a black suit, smiles into the camera.

Stephen B. Montgomery

STANFORD UNIVERSITY

Stephen B. Montgomery is an Associate Professor of Pathology, Genetics and, by courtesy, Computer Science at Stanford University. His laboratory focuses on both functional genomics and bioinformatics approaches to understanding the molecular origins of rare and common genetic diseases. Montgomery has been an active member of multiple large-scale consortia including GREGoR, GTEx and MoTrPAC. His laboratory has developed novel transcriptome-based approaches to identifying impactful rare variants in individuals, families and populations and for measuring gene-by-environment effects.

A white man with a white goatee wearing a purple shirt open at the neck and glasses smiles at the camera.

Hamish S. Scott

Hamish S. Scott, BSc (Hons), PhD, FFSc (RCPA), FAHMS, has transformed his department from being largely diagnostic (40 people) to being a dynamic academic/diagnostic department integrated with basic and clinical research. His department has 35 full-time research personnel and is active in student (science and medical) placements, training (PhDs, registrars, overseas post-docs) and clinical trials. His passion is linking research to diagnostics and clinical translation. He has been imbedded within diagnostic units for all but 8 of his 35 year laboratory career.

Sharon F. Terry

Sharon F. Terry is President and CEO of Genetic Alliance, an enterprise engaging individuals, families and communities to transform health.  Genetic Alliance works to provide programs, products, and tools for ordinary people to take charge of their health and to further biomedical research.